According to Syros Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is โฌ0.35 Million. In 2023 the company made a revenue of โฌ8.98 Million a decrease over the revenue in the year 2022 that were of โฌ13.87 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | โฌ0.34 M | -96.11% |
2023 | โฌ8.98 M | -35.21% |
2022 | โฌ13.87 M | -33.12% |
2021 | โฌ20.73 M | 69.01% |
2020 | โฌ12.27 M | 593.6% |
2019 | โฌ1.76 M | -1.27% |
2018 | โฌ1.79 M | 95.29% |
2017 | โฌ0.91 M | 204.48% |
2016 | โฌ0.3 M | 3.95% |
2015 | โฌ0.28 M |